Specialist life sciences venture capital investor Vesalius Biocapital has closed Vesalius Biocapital III at €120m (US$136.5m). This includes commitments of €30m from the European Investment Fund (EIF) and new and…
Specialist life sciences venture capital investor Vesalius Biocapital has closed Vesalius Biocapital III at €120m (US$136.5m). This includes commitments of €30m from the European Investment Fund (EIF) and new and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference